-
Mashup Score: 16Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy - 4 hour(s) ago
Chemotherapy toxicity tools are rarely studied in patients with hematologic malignancy (HM). The primary aim of this pilot study was to determine the predictive ability of the Cancer and Aging Research Group (CARG) chemo-toxicity calculator in estimating grade 3–5 toxicity in patients with HM.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 37Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology - 18 day(s) ago
Corticosteroids are used frequently in oncology and many patients require short- or long-term corticosteroid therapy. General clinical guidelines and recommendations exist on the use of corticosteroids; however, evidence is lacking for recommendations on their appropriate use in older adult with cancer.Treatment of chemotherapy-induced nausea and vomiting (CINV) has dramatically improved over the last decade with 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists and neurokinin-1 (NK−1) receptor antagonists or a combination of both.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology https://t.co/lzYnAws3J4 @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG https://t.co/hyqY9PmXD1
-
-
Mashup Score: 19Adherence to enhanced recovery after surgery (ERAS) in older adults following colorectal resection - 1 month(s) ago
Enhanced recovery after surgery (ERAS) is an established pathway to improve short-term outcomes in colorectal surgery. It is unclear whether the efficacy, feasibility, and safety of the ERAS protocol are similar in older and younger patients.The study examined adherence to the ERAS protocol and identified factors leading to deviations in older patients.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Adherence to enhanced recovery after surgery (ERAS) in older adults following colorectal resection https://t.co/M8h1768RS7 @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #EnhancedRecoveryAfterSurgery #ERAS #ColorectalSurgery https://t.co/SQaWTPt3jU
-
-
Mashup Score: 22Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer - 2 month(s) ago
Lung cancer kills more people globally than any other cancer [1]. In the United States, it is responsible for more cancer-related deaths than breast, prostate, and colorectal cancer combined [2]. With an average age at diagnosis of 70 years [3], it is often a disease of older adults. Though many clinical trials allow the participation of older adults, they are largely comprised of younger individuals; this limits generalizability to the older adult sitting in front of you in clinic to discuss lung cancer treatment.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer https://t.co/cDOTsc160U @CPresGeriOncMD @efratdotan @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #GFA https://t.co/sBYmVuPokr
-
-
Mashup Score: 17Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancer - 3 month(s) ago
Novel supportive care interventions designed for an aging population with lung cancer are urgently needed. We aimed to determine the feasibility of a novel supportive care physical therapy (PT) plus progressive muscle relaxation (PMR) intervention delivered to older adults with advanced lung cancer in the United States (US).
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): A novel supportive care intervention for older adults with advanced lung cancer https://t.co/UtsyTqlI4a @CPresGeriOncMD @dspakowicz @e_paskett @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults https://t.co/fI9DOhVMzm
-
-
Mashup Score: 10
In France, 40% of patients diagnosed with lung cancer are ≥70 years old, but these are under-represented in clinical trials. Using data from the French Epidemiological Strategy and Medical Economics (ESME) platform on Lung Cancer (LC), the objective is to provide an overview of the management and the prognosis of older patients with advanced or metastatic non-small cell lung cancer (AM-NSCLC) in a real-world context.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database - Journal of Geriatric Oncology https://t.co/FA5hrmrhlz @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #SIOG https://t.co/pMwp0fAg1i
-
-
Mashup Score: 39Geriatric assessment-identified impairments and frailty in adults with cancer younger than 65: An opportunity to optimize oncology care - 3 month(s) ago
Frailty, a state of increased vulnerability to stressors due to aging or treatment-related accelerated aging, is associated with declines in physical, cognitive and/or social functioning, and quality of life for cancer survivors. For survivors aged <65 years, little is known about frailty status and associated impairments to inform intervention. We aimed to evaluate the prevalence of frailty and contributing geriatric assessment (GA)-identified impairments in adults aged <65 versus ≥65 years with cancer.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Geriatric assessment-identified impairments and frailty in adults with cancer younger than 65: An opportunity to optimize oncology care - Journal of Geriatric Oncology https://t.co/TdF5aMIdt2 @mpergolottiPhD @smith__giri @GrantWilliamsMD @WilliamDale_MD @rochgerionc @myCARG https://t.co/gcg6DAKBxY
-
-
Mashup Score: 26Understanding health outcome preferences of older adults diagnosed with multiple myeloma - 4 month(s) ago
Health outcome preferences of older adults with cancer vary based on burden/intensity of treatment and its impact on health outcomes such as survival, quality of life, and functional and cognitive well-being. We studied the association between age and health outcome preferences of adults with multiple myeloma (MM).
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Understanding health outcome preferences of older adults diagnosed with multiple myeloma https://t.co/dukxBvWi4p @smith__giri @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #HealthOutcomePreferences https://t.co/7QEy7LCNdq
-
-
Mashup Score: 26Understanding health outcome preferences of older adults diagnosed with multiple myeloma - 4 month(s) ago
Health outcome preferences of older adults with cancer vary based on burden/intensity of treatment and its impact on health outcomes such as survival, quality of life, and functional and cognitive well-being. We studied the association between age and health outcome preferences of adults with multiple myeloma (MM).
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Understanding health outcome preferences of older adults diagnosed with multiple myeloma https://t.co/dukxBvWi4p @smith__giri @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #HealthOutcomePreferences https://t.co/7QEy7LCNdq
-
-
Mashup Score: 23
The effect of polypharmacy on older patients with cancer is unclear. This study aimed to explore the effect of polypharmacy on the outcomes of treatment in older patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1/PD-L1 inhibitors.
Source: www.geriatriconcology.netCategories: General Medicine News, Oncologists1Tweet-
Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study https://t.co/vzyZb5HBLs @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG https://t.co/xXrhZLUV39
-
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy https://t.co/n3157eUlIQ @Ashley_Rosko1 @SarahAllison10 @KrokSchoen @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier https://t.co/GDk9ZeoSPY